Prostate cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Primary prostate cancer: (1) PSA and routine imaging examinations suggest PCa; (2) No invasive prostate examination or treatment has been performed recently; (3) When the biopsy results of the other hospital (one or more times) are negative and PCa is still highly suspected, the PET/CT/MRI examination should be performed 30 days after the puncture (to avoid the influence of the puncture site); (4) Patients who plan to undergo needle biopsy in our hospital to obtain pathological results (type, location, Gleason grade and score, etc.). 2. Patients with postoperative biochemical recurrence of prostate cancer: (1) Patients with serum PSA level >= 0.1 ng/ml after radical prostatectomy; (2) The first PET/CT/MR examination should be performed before endocrine therapy or radiotherapy; (3) Patients who plan to perform needle biopsy or surgical resection of the lesions detected by PET/MR in our hospital, and the pathological results can be obtained; (4) Patients who have completed PET/CT/MR examination and planned to undergo a second PET/CT/MRI or other imaging methods for follow-up after treatment.
Exclusion criteria
Exclusion criteria: Patients with metal implants such as pacemakers, defibrillators, hearing aids, insulin pumps, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SUVmax;accuracy, specificity, sensitivity; | — |
Countries
China
Contacts
Chinese PLA General Hospital